How are AMGN long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the AMGN long call priced from the end-of-day chain at a 30-day expiry (ATM IV 23.85%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,012.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a AMGN long call?

The breakeven for the AMGN long call priced on this page is roughly $335.13 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMGN market-implied 1-standard-deviation expected move is approximately 6.84%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current AMGN implied volatility affect this long call?

AMGN ATM IV is at 23.85% with IV rank near 22.47%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

AMGN Long Call Strategy

AMGN (Amgen Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NASDAQ.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels.

AMGN (Amgen Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $181.58B, a trailing P/E of 23.29, a beta of 0.44 versus the broader market, a 52-week range of 264.15-391.29, average daily share volume of 2.6M, a public-listing history dating back to 1983, approximately 28K full-time employees. These structural characteristics shape how AMGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.44 indicates AMGN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. AMGN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a long call on AMGN?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current AMGN snapshot

As of May 15, 2026, spot at $327.19, ATM IV 23.85%, IV rank 22.47%, expected move 6.84%. The long call on AMGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this long call structure on AMGN specifically: AMGN IV at 23.85% is on the cheap side of its 1-year range, which favors premium-buying structures like a AMGN long call, with a market-implied 1-standard-deviation move of approximately 6.84% (roughly $22.37 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMGN should anchor to the underlying notional of $327.19 per share and to the trader's directional view on AMGN stock.

AMGN long call setup

The AMGN long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMGN near $327.19, the first option leg uses a $325.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMGN chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMGN shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$325.00	$10.13

AMGN long call risk and reward

Net Premium / Debit: -$1,012.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$1,012.50
Breakeven(s): $335.13
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

AMGN long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on AMGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$1,012.50
$72.35	-77.9%	-$1,012.50
$144.69	-55.8%	-$1,012.50
$217.04	-33.7%	-$1,012.50
$289.38	-11.6%	-$1,012.50
$361.72	+10.6%	+$2,659.71
$434.06	+32.7%	+$9,893.95
$506.41	+54.8%	+$17,128.19
$578.75	+76.9%	+$24,362.43
$651.09	+99.0%	+$31,596.67

When traders use long call on AMGN

Long calls on AMGN express a bullish thesis with defined risk; traders use them ahead of AMGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

AMGN thesis for this long call

The market-implied 1-standard-deviation range for AMGN extends from approximately $304.82 on the downside to $349.56 on the upside. A AMGN long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current AMGN IV rank near 22.47% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AMGN at 23.85%. As a Healthcare name, AMGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMGN-specific events.

AMGN long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMGN alongside the broader basket even when AMGN-specific fundamentals are unchanged. Long-premium structures like a long call on AMGN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current AMGN chain quotes before placing a trade.

Frequently asked questions

What is a long call on AMGN?: A long call on AMGN is the long call strategy applied to AMGN (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With AMGN stock trading near $327.19, the strikes shown on this page are snapped to the nearest listed AMGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AMGN long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the AMGN long call priced from the end-of-day chain at a 30-day expiry (ATM IV 23.85%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,012.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AMGN long call?: The breakeven for the AMGN long call priced on this page is roughly $335.13 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMGN market-implied 1-standard-deviation expected move is approximately 6.84%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on AMGN?: Long calls on AMGN express a bullish thesis with defined risk; traders use them ahead of AMGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current AMGN implied volatility affect this long call?: AMGN ATM IV is at 23.85% with IV rank near 22.47%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.